Abeta 1-42 Antikörper
Kurzübersicht für Abeta 1-42 Antikörper (ABIN1742444)
Target
Alle Abeta 1-42 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Rabbit anti-Abeta42 antibody
-
Spezifität
- Specific for Abeta 42
-
Kreuzreaktivität (Details)
- Reacts with: human (P05067), rat (P08592), mouse (P12023). Other species not tested yet.
-
Aufreinigung
- affinity purified
-
Immunogen
- Synthetic peptide corresponding to the carboxy terminal part of human Abeta42 (UniProt Id: P05067)
-
-
-
-
Applikationshinweise
- WB:1 : 1000 ,
-
Kommentare
-
WB: Detects purified Abeta 42. Complex samples like brain extracts still have to be tested. Nitrocellulose membrane is recommended for blotting.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- For reconstitution add 50 μLH2O to get a 1 mg/mL solution in PBS.
-
Buffer
- PBS. Albumin and azide were added for stabilization.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Do not freeze! Antibodies should be stored at +4°C when still lyophilized.
-
Lagerung
- -20 °C,-80 °C,4 °C
-
Informationen zur Lagerung
- Antibodies should be stored at +4°C when still lyophilized. Then aliquot and store at -20°C to -80°C until use. Albumin and azide were added for stabilization. Do not freeze!
-
-
-
: "Significance of cytosolic cathepsin D in Alzheimer's disease pathology: Protective cellular effects of PLGA nanoparticles against β-amyloid-toxicity." in: Neuropathology and applied neurobiology, Vol. 46, Issue 7, pp. 686-706, (2021) (PubMed).
: "Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease." in: Journal of Alzheimer's disease : JAD, Vol. 44, Issue 4, pp. 1291-302, (2015) (PubMed).
: "Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease." in: Molecular neurodegeneration, Vol. 9, pp. 13, (2014) (PubMed).
: "Aβ38 in the brains of patients with sporadic and familial Alzheimer's disease and transgenic mouse models." in: Journal of Alzheimer's disease : JAD, Vol. 39, Issue 4, pp. 871-81, (2014) (PubMed).
: "Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal A? accumulation." in: Frontiers in aging neuroscience, Vol. 6, pp. 139, (2014) (PubMed).
: "N-truncated amyloid β (Aβ) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits." in: Acta neuropathologica, Vol. 126, Issue 2, pp. 189-205, (2013) (PubMed).
-
: "Significance of cytosolic cathepsin D in Alzheimer's disease pathology: Protective cellular effects of PLGA nanoparticles against β-amyloid-toxicity." in: Neuropathology and applied neurobiology, Vol. 46, Issue 7, pp. 686-706, (2021) (PubMed).
-
- Abeta 1-42 (Amyloid beta 1-42 (Abeta 1-42))
-
Andere Bezeichnung
- Abeta42
-
Hintergrund
-
Synonyms: Beta-APP, ABPP
Antigen Information: Abeta peptides are major components of neuritic plaques in Alzheimer's disease
-
UniProt
- P05067
Target
-